Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Journal of Natural Medicines
Erschienen in:

06.09.2022 | Note

HPLC analysis of ammonium glycyrrhizate listed in the European, United States, and Japanese Pharmacopoeias under reported and modified conditions: revision of the peak assignment for 18α-glycyrrhizin in the European and United States Pharmacopoeias

verfasst von: Kazuaki Kamata, Jin Tatsuzaki, Tsutomu Ishikawa, Ryoko Arai, Takashi Hakamatsuka, Nahoko Uchiyama

Erschienen in: Journal of Natural Medicines | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

We examined ammonium glycyrrhizate listed in the monographs of the European Pharmacopoeia (EP) and United States Pharmacopoeia (USP) as well as in the reagents and solutions used in the general test of the Japanese Pharmacopoeia by performing HPLC on their sample standards or reference reagents under reported and modified conditions. Comparative experiments involving five authentic samples, namely, 18β-glycyrrhizin (1), 18α-glycyrrhizin (2), licorice–saponin G2 (3), licorice–saponin H2 (4), and galacturonic acid-replaced glycyrrhizin (the 4″-epimer of 18β-glycyrrhizin) (5), led us to propose the revision of the peak assignment of 18α-glycyrrhizin (2) and postscript a possible co-existence of galacturonic acid-replaced glycyrrhizin (5) as a hidden component in the EP and USP. We also proposed that the α-configuration used in the nomenclature of the glycosidic bond between aglycone and the sugar units of ammonium glycyrrhizate and impurities in the EP and USP should be revised to the β-configuration.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Hosseinzadeh H, Nassiri-Asl M (2015) Pharmacological effects of Glycyrrhiza spp. and its bioactive constituents: update and review. Phytother Res 29:1868–1886CrossRef
2.
Kao T-C, Wu C-H, Yen G-C (2014) Bioactivity and potential health benefits of licorice. J Agric Food Chem 62:542–553CrossRef
3.
Tolstikovy GA, Baltina LA et al (1997) Glycyrrhizic acid. Russ J Bioorg Chem 23:625–642
4.
Ito Y, Ishizaki K, Sugimoto N, Tada A, Akiyama T, Sato K, Akiyama H, Goda Y (2015) Confirmation of the configuration of two glucuronic acid units in glycyrrhizic acid. Jpn J Food Chem Safety 22:32–37
5.
Miyashita A, Kuramoto T, Okada K (1981) 18α-Glycyrrhizinic acid. UK Patent GB 2071665 A
6.
Baltina LA Jr, Stolyarova OV, Baltina LA, Kondratenko RM, Plyasunova OA, Pokrovskii AG (2010) Synthesis and antiviral activity of 18α-glycyrrhizic acid and its esters. Pharm Chem J 44:299–302CrossRef
7.
Jitrangsri K, Kamata K, Akiba M, Yajiri Y, Ishibashi M, Tatsuzaki J, Ishikawa T (2022) Is 18α-glycyrrhizin a real natural product? Improved preparation of 18α-glycyrrhizin from 18β-glycyrrhizin as a positive standard for HPLC analysis of licorice extracts. J Nat Med 76:376–378CrossRef
8.
“Ammonium glycyrrhizate” in European Pharmacopoeia-10th ed (2019) Vol II Monographs A 01/2017:1772, p 1833–1834
9.
“Ammonium glycyrrhizinate” in British Pharmacopoeia (2021) Vol II-166
10.
“Ammonium glycyrrhizate” in United States Pharmacopoeia-US42/NF37 (2019) NF Monographs: p 5573–5574
11.
Kitagawa I, Hori K, Sakagami M, Zhou J-L, Yoshikawa M (1993) Saponin and sapogenol. XLVIII. On the constituents of the roots of Glycyrrhiza uralensis Fischer from northern China (2). Licorice-saponin D3, E2, F3, G2, H2, J2, and K2. Chem Pharm Bull 41:1337–1345CrossRef
12.
Vora PS (1982) High pressure liquid chromatographic determination of glycyrrhizic acid or glycyrrhizic acid salts in various licorice products: collaborative study. J Assoc Off Anal Chem 65:572–574
13.
Spinks EA, Fenwick GR (1990) The determination of glycyrrhizin in selected UK liquorice products. Food Add Contam 7:769–778CrossRef
14.
Koga K, Ohmachi K, Kawashima S, Takeda K, Murakami M (2000) Determination of 18α-glycyrrhizin and 18β-glycyrrhizin in dog plasma by high-performance liquid chromatography. J Chromatogr B 738:165–158CrossRef
15.
“Monoammonium glycyrrhizinate for resolution check” in The Japanese Pharmacopoeia 18th ed (JP XVIII) (2021) p 328
16.
Uchida M, Wada M, Nakamura H, Ishihara S, Mano N, Komoda Y (1988) Isolation of triterpene glycoside and sweeteners containings it. Japanese Patent JP63267795A
17.
Masada S, Yamaji H, Takeda O, Shimada Y, Komatsu K, Uchiyama N, Hakamatsuka T (2017) 新疆甘草に含まれるグリチルリチン酸及びガラクツログリチルリチン酸量の調査. Nihon Shouyaku Gakkai, 64th annual meeting 1P–76: 199
18.
Goda Y (2017) Studies for quality control of pharmaceuticals focusing on revision of monographs. The Japanese Pharmacopoeia. Research on Regulatory Science of Pharmaceutical and Medical Devices
19.
Kanai K, Hori C, Daikonya A, Harai K, Ou B, Okonogi A, Yokoya Y (2018) Study on shortening of analysis time in high performance liquid chromatography X -Study on quantification of glycyrrhizic acid in JP17 Glycyrrhiza and Powdered Glycyrrhiza. Res Home Med No 37:33–41
20.
Koseki Y (2018) Manufacturing method of glycyrrhizic acid and galacturonic acid glycyrrhizic acid and intermediates used in the method. Japanese Patent P2018104352A
21.
The Pharmaceutical and Medical Device Regulatory Science Society of Japan (ed) (2021) The Japanese Pharmacopoeia 18th ed. In: Technical Information (JPTI 2021). Jiho Inc., Tokyo, pp 1277–1281
Metadaten
Titel
HPLC analysis of ammonium glycyrrhizate listed in the European, United States, and Japanese Pharmacopoeias under reported and modified conditions: revision of the peak assignment for 18α-glycyrrhizin in the European and United States Pharmacopoeias
verfasst von
Kazuaki Kamata
Jin Tatsuzaki
Tsutomu Ishikawa
Ryoko Arai
Takashi Hakamatsuka
Nahoko Uchiyama
Publikationsdatum
06.09.2022
Verlag
Springer Nature Singapore
Erschienen in
Journal of Natural Medicines / Ausgabe 1/2023
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-022-01649-8

Weitere Artikel der Ausgabe 1/2023

Seasonal variation of alkaloids and polyphenol in Ephedra sinica cultivated in Japan and controlling factors

  • Original Paper

Seasonal variation in the total saponin content of platycodon roots cultivated in Japan

  • Original Paper

Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship

  • Note

Correction: Anti-influenza A virus activity of flavonoids in vitro: a structure–activity relationship

  • Correction

Content and distribution of prunasin in Perilla frutescens

  • Note

Lanceolanone A, a new biflavanone, and a chalcone glucoside from the flower heads of Coreopsis lanceolata and their aldose reductase inhibitory activity and AMPK activation

  • Original Paper